Comprehensive
Analysis of the Proteome and PTMomes
of C2C12 Myoblasts Reveals that Sialylation Plays a Role in the Differentiation
of Skeletal Muscle Cells
posted on 2020-11-20, 18:41authored byXiulan Chen, Yaping Sun, Tingting Zhang, Peter Roepstorff, Fuquan Yang
The C2C12 myoblast is a model that
has been used extensively to
study the process of skeletal muscle differentiation. Proteomics has
advanced our understanding of skeletal muscle biology and also the
differentiation process of skeletal muscle cells. However, there is
still no comprehensive analysis of C2C12 myoblast proteomes, which
is important for the understanding of key drivers for the differentiation
of skeletal muscle cells. Here, we conducted multidimensional proteome
profiling to get a comprehensive analysis of proteomes and PTMomes
of C2C12 myoblasts with a TiSH strategy. A total of 8313 protein groups
were identified, including 7827 protein groups from nonmodified peptides,
3803 phosphoproteins, and 977 formerly sialylated N-linked glycoproteins.
Integrated analysis of proteomic and PTMomic data showed that almost
all of the kinases and transcription factors in the muscle cell differentiation
pathway were phosphorylated. Further analysis indicated that sialylation
might play a role in the differentiation of C2C12 myoblasts. Further
functional analysis demonstrated that C2C12 myoblasts showed a decreased
level of sialylation during skeletal muscle cell differentiation.
Inhibition of sialylation with the sialyltransferase inhibitor 3Fax-Neu5Ac
resulted in the lower expression of MHC and suppression of myoblast
fusion. In all, these results indicate that sialylation has an effect
on the differentiation of skeletal muscle cells.